Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study - Takeaways - MDSpire

Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study

  • By

  • Yunzhu Wu

  • Xianhong Wang

  • Cheng Deng

  • Qiu Bi

  • Yang Song

  • Shenghong Ju

  • Yang Liu

  • Conghui Ai

  • Jing Yang

  • July 9, 2026

  • 0 min

Share

  • 1

    This study evaluated multiparametric MRI-based radiomics models to differentiate stage IA endometrial cancer from benign lesions.

  • 2

    A total of 787 patients were included, with tumor regions manually delineated on MRI and peritumoral ROIs generated automatically.

  • 3

    Age and vaginal bleeding were identified as independent clinical predictors of stage IA endometrial cancer.

  • 4

    The combined model of clinical predictors and habitat features achieved the highest diagnostic performance with a peak AUC of 0.921.

  • 5

    K-means clustering demonstrated superior robustness compared to Gaussian Mixture Model in the analysis of peritumoral features.

Original Source(s)

Intratumoral and peritumoral MRI habitat imaging for differentiating stage IA endometrial cancer from benign endometrial lesions: a multicenter study

  • by Yunzhu Wu, Xianhong Wang, Cheng Deng, Qiu Bi, Yang Song, Shenghong Ju, Yang Liu, Conghui Ai, Jing Yang

  • July 9, 2026

Related Content

Global burden and temporal trends of kidney cancer among children from 1990 to 2021: an analysis with projections to 2036

Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study

Correction: Gastric cancer survival prediction using artificial intelligence models based on electronic health records: a systematic review and meta-analysis